Pro Share Advisors LLC Aspira Women'S Health Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.4 - $1.09 $5,451 - $14,855	-13,629 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.88 - $1.81 $1,987 - $4,086	-2,258 Reduced 14.21%	13,629 $14,000
Q4 2021 Feb 08, 2022	BUY	$1.63 - $3.43 $25,895 - $54,492	15,887 New	15,887 $27,000
Q3 2021 Nov 12, 2021	SELL	$3.19 - $5.48 $60,166 - $103,358	-18,861 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.78 - $6.84 $18,632 - $26,662	-3,898 Reduced 17.13%	18,861 $106,000
Q1 2021 May 14, 2021	BUY	$5.9 - $9.13 $30,691 - $47,494	5,202 Added 29.63%	22,759 $154,000
Q4 2020 Feb 09, 2021	BUY	$3.0 - $6.71 $52,671 - $117,807	17,557 New	17,557 $118,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.